SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis

We read with interest the article “SARS-CoV-2 infection in patients with autoimmune Hepatitis” by Marjot et al. [1] recently published in the Journal of hepatology. While immunosuppressive therapy for autoimmune hepatitis (AIH) had no negative impact on the immediate outcome of COVID-19 [1-3], the question remained, whether COVI D-19 convalescents immunosuppressed for AIH (AIH-Con) are protected from a SARS-CoV-2 reinfection as non-immunosuppressed convalescents (non-IS-Con).
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research